Learn / NPCE
NASDAQ: NPCE
NeuroPace (NPCE) stock, explained like you're 5
NeuroPace trades on the Nasdaq under the ticker NPCE. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 435 million dollars.
- Ticker
- NPCE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical/Dental Instruments
- Size
- Small cap, about 435 million dollars
Is NeuroPace a small, medium or large cap company?
No. NeuroPace is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 435 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How NeuroPace makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NPCE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- NeuroPace, Inc. (NPCE) What Are Brokerages Saying About This Stock? (MarketBeat)
- Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now (Yahoo Finance)
- NPCE Forecast Price Target Prediction for 2027 (TradingView)
- The Technical Signals Behind (NPCE) That Institutions Follow (Stock Traders Daily)
- After shares were withheld for taxes, NeuroPace (NPCE) medical chief Martha Morrell held 51,357 shares. (Stock Titan)
Follow NPCE in your daily brief
Each trading day at 5 PM ET we post what happened to NeuroPace and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NPCE
Questions about NeuroPace stock
What does NeuroPace do?
NeuroPace trades on the Nasdaq under the ticker NPCE. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 435 million dollars.
What is the ticker symbol for NeuroPace?
NeuroPace trades under the ticker NPCE on the Nasdaq.
What is NeuroPace's market cap?
NeuroPace is a small cap stock with a market cap of about 435 million dollars.
How does NeuroPace make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NPCE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NPCE stock every day?
Add NPCE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.